Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study

author
created [InstanceEdit:9618320] Jassal, Bijay, 2018-09-05
dbId 9618332
displayName Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study
journal Pharmacol Res Perspect
pubMedIdentifier 28971615
schemaClass LiteratureReference
title Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study
url http://www.ncbi.nlm.nih.gov/pubmed/28971615
volume 5
year 2017
Cite Us!